Description
Developer of biological injectables intended to revolutionize the field of biotechnology. The company's injectables are created from microbial or human recombinant fermentation processes that can be used in preclinical, clinical, and commercial uses, enabling clients to avail global macromolecular biotech products equipped with new technologies.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Seed Round | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230013981-A1 | Water-dispersible dry powder formulation and production method thereof | Pending | 12-Jul-2021 | 0000000000 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Steve Hsu Ph.D | Founder, Chief Executive Officer & Chairman | ||
Kai-Der Ko | CSO & Vice President |
Name | Representing | Role | Since |
---|---|---|---|
Steve Hsu Ph.D | Genovior Biotech | Founder, Chief Executive Officer & Chairman | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Taipei Angels | Angel Group | Minority | 000 0000 | 000000 0 |